Innovatus Capital Partners, LLC focuses on capitalizing on market distress, disruption, and growth through long-term investments. The firm typically engages in various investment stages, including Series B, Series C, Series D, and beyond, as well as post-IPO debt and equity financing. Their investment strategy leverages market volatility to scale opportunities, lock in premiums, and build durable income streams.
Notable portfolio companies include Akoya Biosciences, Cala Health, Dnanexus, Eiger BioPharmaceuticals, and Geneoscopy. Innovatus is led by key partners with a deep understanding of market dynamics and a philosophy centered on long-term capital deployment. The firm offers unique value-add services such as strategic guidance and operational support to help portfolio companies navigate and capitalize on market disruptions.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.